
Acelostat P Tab
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
Distributor inventory | Tablet
Sitagliptin 100 mg + Dapagliflozin 10 mg
Type 2 diabetes mellitus: to improve glycaemic control in adults as an adjunct to diet and exercise when treatment with both agents is appropriate.
Sitagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), enhancing glucose-dependent insulin release and reducing glucagon. Dapagliflozin is an SGLT2 inhibitor that reduces renal glucose reabsorption, increasing urinary glucose excretion and lowering blood glucose.
Oral tablet; typically taken once daily as prescribed. Can be taken with or without food; take at the same time each day. Swallow whole with water; do not crush/chew. Dose adjustments may be needed in kidney impairment—follow doctor’s advice.
Common side effects of Ziasit-D 100/10MG Tab 10S may include:

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 200 mg - 10 S
Standard delivery
Not for type 1 diabetes or diabetic ketoacidosis. Risk of dehydration/hypotension—ensure adequate fluids, especially in elderly or with diuretics. SGLT2 inhibitors may rarely cause ketoacidosis even with near-normal sugars—seek urgent care for nausea/vomiting, abdominal pain, rapid breathing. Increased risk of genital mycotic infections and UTIs; maintain hygiene and report symptoms. Monitor kidney function before and during therapy; avoid/initiate with caution in significant renal impairment as per prescriber. Rare risk of pancreatitis with sitagliptin—stop and seek care if severe persistent abdominal pain. Risk of hypoglycaemia when used with insulin or sulfonylureas—dose reduction of those agents may be required. Inform doctor before surgery/fasting; medicine may be temporarily stopped.